Target intelligence / Profile preview

Neisseria meningitidis Polysaccharide Capsule (N/A)

Target
N/A
Molecular classification
Polysaccharide, Capsule, Antigen
01

Overview

The polysaccharide capsule of *Neisseria meningitidis* is a high-molecular-weight carbohydrate structure that surrounds the bacterial cell and is a major virulence factor. It allows the bacterium to evade the host's immune system, causing invasive diseases like meningitis and septicemia. Different serogroups are defined by the capsule's chemical composition, with serogroups A, B, C, W, X, and Y being the most common causes of disease. The capsule is a key target for vaccine development, with conjugate vaccines available for serogroups A, C, W, and Y. However, the serogroup B capsule's similarity to human neural tissue presents challenges for vaccine design. Capsule switching and phase variation contribute to immune evasion and complicate diagnostic efforts.

Other names
Meningococcal CapsuleCapsular PolysaccharideCPS
02

Mechanism of action

Antibodies targeting the capsule promote opsonization and complement-mediated killing.

03

Biological functions

Immune evasionComplement resistanceAntiphagocytosisSurvival in bloodstreamAdhesion
04

Disease associations

MeningitisSepticemiaInvasive Meningococcal Disease
05

Safety considerations

Serogroup B capsule mimicry of human neural tissue (complicating vaccine development)Capsule switching (leading to vaccine escape)Potential for autoimmune reactions (related to serogroup B)
06

Interacting drugs

Conjugate Vaccines (targeting A, C, W, Y serogroups)

1 more in the full profile.

07

Biomarkers

Capsular serogroup (for vaccine selection and outbreak monitoring)Antibody titers against specific serogroups (for assessing vaccine efficacy)

Beyond the preview

Go deeper on Neisseria meningitidis Polysaccharide Capsule (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis Polysaccharide Capsule (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call